Qiagen, Exosome Diagnostics Partner to Develop Sample Prep Kits | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen and Exosome Diagnostics have inked a partnership to develop and commercialize co-branded kits to capture and process RNA and DNA from biofluid exosomes and other microvesicles, the companies said after the markets closed on Tuesday.

As part of the agreement, the companies will combine Exosome's proprietary exosome platform technology with select Qiagen consumables and automation platforms, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.